IRIS UniCatt

De Stefano, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.323
EU - Europa 6.421
AS - Asia 5.887
SA - Sud America 1.542
AF - Africa 174
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.086
SG - Singapore 3.069
DE - Germania 1.654
CN - Cina 1.388
BR - Brasile 1.265
SE - Svezia 1.177
IT - Italia 986
UA - Ucraina 487
FR - Francia 413
IE - Irlanda 360
GB - Regno Unito 334
VN - Vietnam 326
ID - Indonesia 250
PL - Polonia 245
FI - Finlandia 242
IN - India 238
RU - Federazione Russa 181
AR - Argentina 117
CA - Canada 104
MX - Messico 89
HK - Hong Kong 76
IQ - Iraq 76
AT - Austria 70
JP - Giappone 68
TR - Turchia 66
BD - Bangladesh 63
ES - Italia 43
NL - Olanda 42
BE - Belgio 40
KR - Corea 40
ZA - Sudafrica 40
EC - Ecuador 33
PK - Pakistan 33
CO - Colombia 29
CI - Costa d'Avorio 28
VE - Venezuela 28
SA - Arabia Saudita 25
CZ - Repubblica Ceca 23
IR - Iran 22
MA - Marocco 21
AU - Australia 20
CL - Cile 20
LT - Lituania 19
PY - Paraguay 18
UZ - Uzbekistan 18
KE - Kenya 17
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 15
CH - Svizzera 15
TN - Tunisia 15
DZ - Algeria 14
RO - Romania 14
JO - Giordania 13
PE - Perù 13
UY - Uruguay 12
IL - Israele 11
EG - Egitto 10
HU - Ungheria 9
CR - Costa Rica 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
NP - Nepal 8
PT - Portogallo 8
ET - Etiopia 7
MD - Moldavia 7
OM - Oman 7
BG - Bulgaria 6
BO - Bolivia 6
GR - Grecia 6
JM - Giamaica 6
LV - Lettonia 6
MY - Malesia 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
AM - Armenia 5
DK - Danimarca 5
EE - Estonia 5
NO - Norvegia 5
PH - Filippine 5
TH - Thailandia 5
TW - Taiwan 5
BH - Bahrain 4
GT - Guatemala 4
HR - Croazia 4
KG - Kirghizistan 4
PA - Panama 4
BB - Barbados 3
BY - Bielorussia 3
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
NI - Nicaragua 3
RS - Serbia 3
CG - Congo 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GH - Ghana 2
LB - Libano 2
Totale 21.346
Salva come PNG Salva come JPEG
Città #
Singapore 1.391
Chandler 1.169
Ashburn 656
Dublin 352
Beijing 289
Jacksonville 277
San Mateo 277
Munich 254
Jakarta 222
Wilmington 212
Dallas 211
Warsaw 206
Los Angeles 203
New York 188
Nanjing 187
Rome 180
Boston 166
Ann Arbor 161
Cattolica 160
Milan 150
Fairfield 147
Dearborn 143
Hefei 131
Houston 122
Woodbridge 122
Moscow 104
Ho Chi Minh City 100
Princeton 100
Redmond 95
São Paulo 95
Marseille 91
Hanoi 90
Lawrence 90
Seattle 90
Chicago 87
Helsinki 83
Frankfurt am Main 75
Redwood City 75
Hong Kong 73
Nanchang 68
Hyderabad 63
Buffalo 55
The Dalles 52
Nürnberg 49
Nuremberg 45
Rio de Janeiro 44
Tokyo 44
Bremen 43
Boardman 41
Belo Horizonte 38
Kent 37
Norwalk 37
Brussels 36
London 36
Hebei 35
Seoul 35
Kunming 33
Mountain View 33
Vienna 32
Cambridge 31
Santa Clara 30
Toronto 30
University Park 30
Abidjan 28
Hangzhou 28
San Francisco 28
Zhengzhou 28
Detroit 27
Florence 27
Shenyang 27
Tianjin 27
Düsseldorf 26
Lancaster 26
Pune 26
Washington 26
Jiaxing 25
Leawood 25
Turku 25
Brooklyn 24
Izmir 24
Paris 24
Baghdad 23
Kraków 23
Montreal 23
Changsha 22
Dhaka 22
Mexico City 22
Atlanta 21
Guangzhou 21
Johannesburg 21
Porto Alegre 21
Campinas 20
Curitiba 20
Poplar 20
Roubaix 20
Lappeenranta 19
Da Nang 18
Orem 18
Shanghai 18
Casalecchio di Reno 17
Totale 10.661
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 319
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 314
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 306
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 261
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 247
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 225
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 216
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 196
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 186
Risk factor and etiology analysis of ischemic stroke in young adult patients 182
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 177
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 169
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 168
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 167
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 167
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 164
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 161
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 161
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 160
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 158
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 158
A real-time integrated framework to support clinical decision making for covid-19 patients 157
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 154
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 152
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 148
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 147
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 147
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 146
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 146
Venous thromboembolism in multiple myeloma 143
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 141
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 140
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 140
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 140
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 137
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 136
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 134
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 133
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 132
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 131
Postpartum hemorrhage 127
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 125
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 125
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 125
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 124
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 123
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 123
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 122
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 122
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 122
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 121
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 121
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 121
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 121
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 119
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 118
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 118
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 113
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 112
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 112
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 111
Inherited thrombophilia: treatment during pregnancy. 111
Ineherited Thrombophilia: treatment during pregnancy 111
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 111
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 111
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 109
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 108
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 107
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 107
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 106
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 106
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 105
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 104
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 104
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 100
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 99
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 99
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 99
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 99
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 98
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 98
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 98
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 97
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 96
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 96
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 95
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 94
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 94
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 94
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 94
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 93
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 93
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 93
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 93
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient with Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 91
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 91
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 90
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 90
Totale 13.404
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021730 0 0 0 0 0 75 137 29 145 47 271 26
2021/20221.674 130 103 25 76 100 29 24 259 81 108 320 419
2022/20233.370 509 476 294 484 206 378 178 226 368 91 110 50
2023/20241.742 74 506 57 78 77 234 107 96 32 60 188 233
2024/20254.006 98 135 275 122 337 114 217 215 638 392 766 697
2025/20265.686 1.528 320 761 1.125 1.830 122 0 0 0 0 0 0
Totale 21.684